Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience. (Q54106224)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience. |
scientific article |
Statements
Long-term results from a phase II study of single agent paclitaxel (Taxol) in previously platinum treated patients with advanced ovarian cancer: the Nordic experience. (English)
C Tropé
T Hogberg
J Kaern
K Bertelsen
E Bjorkholm
K Boman
A Himmelmann
G Horvath
A Jacobsen
T Kuoppola
J Vartianen
B Lund
M Onsrud
U Puistola
T Salmi
M Scheistroen
R Sandvei
E Simonsen
B Sorbe
B Tholander
R Westberg
1 December 1998
9
12
1301-1307